Grant: Engage Grants Program
Université Laval
$25,000.00
Probiotic mechanism of action through the microbiome-endocannabinoidome axis
FY 2018-19
Summary
The human gastrointestinal track is an ecosystem; home to trillions of micro-organisms collectively known*as the gut microbiome. Recent advances in our understanding of the gut microbiome has uncovered the many*ways in which it impacts on our health: modulating our ability to digest and absorb nutrients and influence the*regulation of whole body energy metabolism; affecting inflammation; and influencing feelings and behaviour.*The gut microbiome does this by interacting with many of the body's endogenous molecular pathways that*regulate the various aspects of human physiology and pathology. One such system is the endocannabinoid*system: a large family of fatty acid-derived molecules, the original members of which activate the same protein*as the active component of cannabis. The endocannabinoid system is a key regulator of many physiological*processes, including: metabolism, inflammation and neuronal activity. Given the gut microbiome's vital roles*in human health, it is now considered as a type of organ system that must be taken care of through the*consumption of a healthy diet and a valid target for the development of therapeutics. Probiotics: live*micro-organisms, that, when consumed in adequate amounts confer health benefits are one way in which the*gut microbiome can be targeted. Bio-K+ is a world leader in the production of probiotics that have verified*benefits to human health; however, the mechanisms by which these probiotics elicit these effects remains to be*determined. We hypothesize that consumption of bacterial strains within Bio-K+ probiotics results in*significant modifications to the gut microbiome and endocannabinoid system. Gaining an understanding of the*effects Bio-K+ probiotics have on these systems will provide insight into the mechanisms by which Bio-K+*probiotics impact human health and aid in the identification and development of new probiotic products.
Program
Engage Grants Program
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
524530-2018
Name nom
DiMarzo, Vincenzo
Department département
Nutraceutiques et des aliments fonctionnels, Institut des (INAF)
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
1
Nb partie
1
Application title
Probiotic mechanism of action through the microbiome-endocannabinoidome axis
Keyword
NSERC
Application summary
The human gastrointestinal track is an ecosystem; home to trillions of micro-organisms collectively known*as the gut microbiome. Recent advances in our understanding of the gut microbiome has uncovered the many*ways in which it impacts on our health: modulating our ability to digest and absorb nutrients and influence the*regulation of whole body energy metabolism; affecting inflammation; and influencing feelings and behaviour.*The gut microbiome does this by interacting with many of the body's endogenous molecular pathways that*regulate the various aspects of human physiology and pathology. One such system is the endocannabinoid*system: a large family of fatty acid-derived molecules, the original members of which activate the same protein*as the active component of cannabis. The endocannabinoid system is a key regulator of many physiological*processes, including: metabolism, inflammation and neuronal activity. Given the gut microbiome's vital roles*in human health, it is now considered as a type of organ system that must be taken care of through the*consumption of a healthy diet and a valid target for the development of therapeutics. Probiotics: live*micro-organisms, that, when consumed in adequate amounts confer health benefits are one way in which the*gut microbiome can be targeted. Bio-K+ is a world leader in the production of probiotics that have verified*benefits to human health; however, the mechanisms by which these probiotics elicit these effects remains to be*determined. We hypothesize that consumption of bacterial strains within Bio-K+ probiotics results in*significant modifications to the gut microbiome and endocannabinoid system. Gaining an understanding of the*effects Bio-K+ probiotics have on these systems will provide insight into the mechanisms by which Bio-K+*probiotics impact human health and aid in the identification and development of new probiotic products.